Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04483505
Title Rogaratinib, Palbociclib y Fulvestrant in Patients With Breast Cancer. (ROGABREAST)
Recruitment Recruiting
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors Fundacion CRIS de Investigacion para Vencer el Cancer

Her2-receptor negative breast cancer


Fulvestrant + Palbociclib + Rogaratinib

Age Groups: adult | senior
Covered Countries ESP

Additional content available in CKB BOOST